MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 1 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $33,422,000 | 5.35% |
| Cormorant Asset Management, LP | 3,193,973 | $69,550,000 | 2.36% |
| NEA Management Company, LLC | 7,703,205 | $174,863,000 | 2.28% |
| Octagon Capital Advisors LP | 238,045 | $5,404,000 | 1.12% |
| Avoro Capital Advisors LLC | 3,311,434 | $62,153,000 | 1.08% |
| Alphabet Inc. | 1,464,015 | $33,233,000 | 0.68% |
| Logos Global Management LP | 300,000 | $6,810,000 | 0.57% |
| Casdin Capital, LLC | 960,883 | $21,812,000 | 0.55% |
| RTW INVESTMENTS, LP | 1,214,572 | $25,228,000 | 0.38% |
| Monashee Investment Management LLC | 120,000 | $2,724,000 | 0.33% |